Abstract
Opioid use disorder (OUD) is a known risk factor for pregnancy-related maternal deaths and greatly contributes to other obstetrical and neonatal complications. Physicians are urged to obtain a US Drug Enforcement Administration (DEA) waiver (x-waiver) to reduce use associated risks through prescribing buprenorphine. This study aims to observe the number and geographic distribution of x-waivered physicians in New York (NY), with a focus on OB/GYN providers.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
